During pregnancy, clotting factors increase in pregnant women, leading to an increased risk of developing coagulopathies. The thromboelastography test provides a dynamic and visualized view of coagulation in pregnant women.
During pregnancy, thrombin and most coagulation factors increase and the blood is in a hypercoagulable state. This is a physiologic protective mechanism that provides the necessary physiologic basis for hemostasis of the placental abruption surface after delivery, but it also simultaneously increases the risk of recurrent miscarriage, disseminated intravascular coagulation, and thrombosis.
Conventional coagulation tests are time-consuming, lack dynamics, and do not directly reflect the cause of coagulation disorders. Thromboelastography, on the other hand, can observe patients’ coagulation function dynamically, quickly and intuitively, and is a good predictor of deep vein thrombosis and disseminated intravascular coagulation.
In conclusion, it is recommended to perform the thromboelastography test as prescribed by the doctor so that the doctor can assess the coagulation status of pregnant women.